Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Obesity data

Obesity data

Obesity data
Obesity data from Phase II and later trials. Data for marketed drugs taken from the labels. (A) Number of patients not available; (B) Weight reductions converted to pounds from kilograms
Company Product [current status] Study details

Read the full 404 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE